Harborview Medical Center, Seattle
Harborview Medical Center partnered with Public Health—Seattle & King County (PHSKC) to improve access to COVID-19 testing and vaccination for low-income and minority populations, people with limited English proficiency (LEP), and people experiencing homelessness. Harborview created mobile walk-up, no-cost testing and vaccination sites at locations that were easily accessible and trusted by at-risk communities, including churches, mosques, schools, housing units, homeless shelters, encampments, and food banks.
From April 2020 to March 2021, Harborview and PHSKC performed 21,758 COVID-19 tests at more than 50 sites. From February to October 2021, mobile outreach teams administered 9,457 vaccine doses at more than 97 locations; of those vaccinated, 70 percent identified as Black, indigenous, and people of color, one-third were from a LEP population, and 14 percent were housing insecure.
University Medical Center of El Paso, El Paso, Texas
Since December 2020, University Medical Center of El Paso has administered 327,000 COVID-19 vaccines through a central hub site, four neighborhood health clinics, a mobile health clinic, and two county jail facilities. UMC also staffed Texas’ first binational COVID-19 vaccine effort between El Paso and its sister city, Ciudad Juárez, Mexico, which had a 30 percent vaccination rate before the health system intervened.
As of November 29, 2021, 91.7 percent of community members 65 and older were fully vaccinated and 99.9 percent were partially vaccinated. As of early October, 75.8 percent of those 12 and older were fully vaccinated and 87.9 percent partially vaccinated, and 69.3 percent of those 5 and older were fully vaccinated and 84.7 percent partially vaccinated.
University of Texas Medical Branch, Galveston, Texas
To help physicians and patients interpret test results for SARS-CoV-2, the virus that causes COVID-19, University of Texas Medical Branch (UTMB) pathology faculty in October 2020 developed a compendium of expert interpretive commentary and a supporting application that applies these comments to tests and delivers them to physicians and patients.
In 13 months, UTMB completed more than 325,000 test interpretations and monitored COVID-19 outcomes to assess whether better distribution of COVID-19 test results reduced diagnostic ambiguity and led to better outcomes. UTMB had:
- a mean length of stay of 6.5 days, compared with an 8.3-day regional average and 9.1-day national average;
- a 4.4 percent rate of escalation to the intensive care unit, compared with a 22.6 percent regional rate and 23.3 percent national rate; and
- a mortality rate of 7 percent, compared with a 10.1 percent regional rate and 12.7 percent national rate.